Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($0.62), $0.02 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $2.39 billion versus the consensus estimate of $2.46 billion.

GUIDANCE:

Oscar Health Inc. sees FY2025 revenue of $11.2-11.3 billion, versus the consensus of $11.69 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.